New Key Statistics Module, Z-Score and F-Score
NAS:SRPT Key Ratios
| Market Cap $ M | 12,460.12 |
| Enterprise Value $ M | 12,448.73 |
| P/E(ttm) | 329.55 |
| PE Ratio without NRI | 173.22 |
| Forward PE Ratio | 40.16 |
| Price/Book | 12.96 |
| Price/Sales | 8.98 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,403.00 |
| EPS (TTM) $ | 0.40 |
| Beneish M-Score | -1.25 |
| 10-y EBITDA Growth Rate % | -7.80 |
| 5-y EBITDA Growth Rate % | 3.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 230.90 |
| EV-to-EBITDA | 130.01 |
| PEG | 55.88 |
| Shares Outstanding M | 94.52 |
| Net Margin (%) | 1.20 |
| Operating Margin % | -6.76 |
| Pre-tax Margin (%) | 2.43 |
| Quick Ratio | 3.44 |
| Current Ratio | 4.05 |
| ROA % (ttm) | 0.54 |
| ROE % (ttm) | 2.09 |
| ROIC % (ttm) | -4.09 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.57 |
SRPT Number of Guru Trades
SRPT Volume of Guru Trades
Gurus Latest Trades with NAS:SRPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRPT is held by these investors
Total 3
Sarepta Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SRPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers